Lv3
360 积分 2024-07-31 加入
What the Gantenerumab Trials Teach Us about Alzheimer’s Treatment
1个月前
已完结
Telitacicept: A novel horizon in targeting autoimmunity and rheumatic diseases
1个月前
已完结
Multiple sclerosis progression: time for a new mechanism-driven framework
2个月前
已完结
Ageing and multiple sclerosis
2个月前
已完结
Inhibition of CD40L with Frexalimab in Multiple Sclerosis
2个月前
已完结
Obexelimab in Systemic Lupus Erythematosus With Exploration of Response Based on Gene Pathway Co-Expression Patterns: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial
2个月前
已完结
Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial
2个月前
已完结
Hypoxia drives CD39-dependent suppressor function in exhausted T cells to limit antitumor immunity
3个月前
已完结
Humanized mouse models for immuno-oncology research
3个月前
已完结
皖公网安备34019202002308
